4//SEC Filing
GUALBERTO ANTONIO 4
Accession 0001209191-19-041911
CIK 0001422143other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:04 PM ET
Size
12.9 KB
Accession
0001209191-19-041911
Insider Transaction Report
Form 4
GUALBERTO ANTONIO
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-07-10$6.15/sh+18,000$110,700→ 357,973 total - Exercise/Conversion
Option to purchase common stock
2019-07-10−18,000→ 151,000 totalExercise: $6.15Exp: 2027-01-22→ Common Stock (18,000 underlying) - Sale
Common Stock
2019-07-10$21.11/sh−18,000$379,903→ 339,973 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
- [F2]This transaction was executed in multiple trades at prices ranging from $21.10 to $21.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- [F3]This option vests in 48 equal monthly installments commencing on the grant date.
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001635794
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:04 PM ET
- Size
- 12.9 KB